Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme

AIMS: To evaluate the efficacy and safety of oral semaglutide versus comparators by patient characteristic subgroups in patients with type 2 diabetes. MATERIALS AND METHODS: Change from baseline in glycated haemoglobin (HbA1c) and body weight, and achievement of HbA1c <7.0% with oral semaglutide...

Descripción completa

Detalles Bibliográficos
Autores principales: Aroda, Vanita R., Bauer, Robert, Christiansen, Erik, Haluzík, Martin, Kallenbach, Klaus, Montanya, Eduard, Rosenstock, Julio, Meier, Juris J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321749/
https://www.ncbi.nlm.nih.gov/pubmed/35373893
http://dx.doi.org/10.1111/dom.14710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321749/
https://www.ncbi.nlm.nih.gov/pubmed/35373893
http://dx.doi.org/10.1111/dom.14710

Ejemplares similares